Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by

Janine L Oliver1, Matthew P Alexander, Allison G Norrod

  • 1Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA.

Insights

Metastatic melanomas produce osteoprotegerin (OPG), a factor linked to aggressive cancer. This production is regulated by tumor necrosis factor-alpha (TNF-α) signaling via TNF receptor 1 (TNFR1), offering a new therapeutic target.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumors evade immune responses via secreted factors and decoy receptors.
  • Osteoprotegerin (OPG), a TNF receptor superfamily member, regulates bone remodeling and T cell apoptosis.
  • OPG production in cancers correlates with aggressive phenotypes and bone metastasis.

Purpose of the Study:

  • To investigate OPG production in human metastatic melanoma.
  • To elucidate the regulatory mechanism of OPG production in melanoma.
  • To identify potential therapeutic targets for regulating OPG in melanoma.

Main Methods:

  • Analysis of OPG expression in human metastatic melanoma samples.
  • Investigation of the role of tumor necrosis factor-alpha (TNF-α) and TNF receptor 1 (TNFR1) signaling.
  • Assessment of OPG production mechanisms.

Main Results:

  • A significant proportion of human metastatic melanomas constitutively produce OPG.
  • Melanoma OPG production is regulated by membrane-bound TNF-α signaling through TNFR1.
  • This pathway represents a novel mechanism controlling OPG in melanoma.

Conclusions:

  • Human metastatic melanomas produce OPG via a TNF-α/TNFR1-dependent mechanism.
  • This finding establishes a specific regulatory pathway for OPG in melanoma.
  • The TNF-α/TNFR1 pathway is a potential therapeutic target for managing OPG in metastatic melanoma.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...